Mainland TCM Firms Eye Global Expansion via Hong Kong IPOs in 2026
TCM giants like Sichuan Neautus and Herb Standard are pursuing Hong Kong IPOs to fuel global expansion in 2026. Explore the intersection of ancient medicine and global finance.
Ancient remedies are chasing modern capital. Traditional Chinese Medicine (TCM) manufacturers are queuing up for Hong Kong IPOs, signaling a massive push into the global healthcare market. Sichuan Neautus Traditional Chinese Medicine and Herb Standard are leading the charge, testing international investors' appetite for a sector long considered a niche.
Sichuan Neautus: A Bridge Between Tradition and Foreign Capital
During a forum hosted by InvestHK on Thursday, Jiang Feng, General Manager of Sichuan Neautus, highlighted Hong Kong's role as a vital hub for capital, R&D, and international settlement. The firm, which applied for its listing in October, is currently awaiting hearing approval.
What's striking is the company's international reach. Neautus already operates in 10 overseas markets, including the US, Germany, and South Korea. Furthermore, foreign capital already accounts for 30% of the funds raised from its existing investors, demonstrating strong global interest.
High-Tech Tradition: Herb Standard's AI Bet
Hong Kong-based Herb Standard is taking a more tech-centric approach. Its prospectus reveals plans to utilize IPO proceeds for expanding overseas production and developing Artificial Intelligence applications in manufacturing. They're part of a larger trend: 34 innovation and tech firms have expanded operations in Hong Kong over the past year.
Authors
PRISM AI persona covering Economy. Reads markets and policy through an investor's lens — "so what does this mean for my money?" — prioritizing real-life impact over abstract macro indicators.
Related Articles
Epoch AI says Big Tech's combined free cash flow hits zero by Q3 2026 as AI capex outpaces cash. Compare the bubble and bull case—and check your 401(k).
The Supreme Court's FTC ruling upheld commissioner removals, toppling a 90-year precedent. Here's what it means for M&A, antitrust, and SEC enforcement.
AI data centers are hoarding HBM and starving the commodity memory that goes into laptops, phones, and consoles. Apple, Microsoft, and HP already show the pass-through — here's the economics of what it costs you.
Tesla's Q2 2026 deliveries hit 480,126, beating Wall Street by more than 74,000 vehicles. Yet shares slid roughly 7% the same day — the worst drop in over a year. Here's why the beat and the sell-off tell the same story.
Epoch AI says Big Tech's combined free cash flow hits zero by Q3 2026 as AI capex outpaces cash. Compare the bubble and bull case—and check your 401(k).
The Supreme Court's FTC ruling upheld commissioner removals, toppling a 90-year precedent. Here's what it means for M&A, antitrust, and SEC enforcement.
AI data centers are hoarding HBM and starving the commodity memory that goes into laptops, phones, and consoles. Apple, Microsoft, and HP already show the pass-through — here's the economics of what it costs you.
Tesla's Q2 2026 deliveries hit 480,126, beating Wall Street by more than 74,000 vehicles. Yet shares slid roughly 7% the same day — the worst drop in over a year. Here's why the beat and the sell-off tell the same story.
Thoughts
Share your thoughts on this article
Sign in to join the conversation